About This Formulation
This compounded oral formulation contains BPC-157 and KPV, peptides that have been investigated for activity involving cellular, tissue-related, and inflammatory signaling pathways.
Human clinical evidence regarding these ingredients remains limited, and this compounded formulation is not an FDA-approved drug.
Treatment is considered only following an individualized medical evaluation. Your provider will review your medical history, current medications, treatment goals, potential risks, and available treatment options before determining whether treatment is clinically appropriate.
Reviews
There are no reviews yet.